Unique Genetic Profiles in Hypertrophic Cardiomyopathy Patients From São Miguel Island (Azores, Portugal)

Fabiana Duarte,Luís Oliveira,Márcia Baixia,Luísa Mota‐Vieira,Carina Machado
DOI: https://doi.org/10.1111/cge.14656
2024-11-30
Clinical Genetics
Abstract:This is the first study to examine the clinical characteristics and molecular diagnosis of adult HCM patients from São Miguel Island. Novel variants and genotypes identified include large multi‐exon deletions in MYBPC3, a homozygous missense variant in TNNT2, and a digenic heterozygous variant in TNNT2/MYH7. To investigate the clinical features and mutational spectrum underlying hypertrophic cardiomyopathy (HCM) in São Miguel Island (Azores, Portugal), we analyzed 37 adult patients (12 sporadic, 25 familial) with positive genetic tests. Seven disease‐causing variants were identified, being two novels, in three sarcomeric genes (MYH7, TNNT2, and MYBPC3) and one non‐sarcomeric gene (ALPK3). The novel variants, classified as likely pathogenic (LP), involved large multi‐exon deletions in MYBPC3 (exons 26–32 and 28–33). These deletions were found in heterozygosity in two young males who remained clinically stable, though early onset may predict a more severe prognosis. Segregation analysis in a consanguineous family revealed two new genotypes: a digenic heterozygous for MYH7:c.1750G>C (p.Gly584Arg; P) and TNNT2:c.842A>T (p.Asn281Ile; LP) variants, and a homozygous for the TNNT2 variant. The 70‐year‐old homozygous patient remained stable and without arrhythmic events, challenging the belief that homozygous variants have a worse prognosis. This study is the first molecular and clinical analysis of HCM in the Azores.
genetics & heredity
What problem does this paper attempt to address?